India · Delayed Price · Currency is INR Artemis Medicare Services Statistics
Total Valuation
NSE:ARTEMISMED has a market cap or net worth of INR 43.85 billion. The enterprise value is 44.46 billion.
| Market Cap | 43.85B |
| Enterprise Value | 44.46B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
NSE:ARTEMISMED has 158.31 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | 158.31M |
| Shares Outstanding | 158.31M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 3.08% |
| Owned by Institutions (%) | 1.50% |
| Float | 32.29M |
Valuation Ratios
The trailing PE ratio is 42.23 and the forward PE ratio is 32.72. NSE:ARTEMISMED's PEG ratio is 1.15.
| PE Ratio | 42.23 |
| Forward PE | 32.72 |
| PS Ratio | 4.06 |
| PB Ratio | 4.66 |
| P/TBV Ratio | 4.98 |
| P/FCF Ratio | 162.41 |
| P/OCF Ratio | 33.23 |
| PEG Ratio | 1.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.63, with an EV/FCF ratio of 164.68.
| EV / Earnings | 42.91 |
| EV / Sales | 4.11 |
| EV / EBITDA | 23.63 |
| EV / EBIT | 31.74 |
| EV / FCF | 164.68 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.74 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 9.69 |
| Interest Coverage | 5.06 |
Financial Efficiency
Return on equity (ROE) is 11.63% and return on invested capital (ROIC) is 11.50%.
| Return on Equity (ROE) | 11.63% |
| Return on Assets (ROA) | 6.29% |
| Return on Invested Capital (ROIC) | 11.50% |
| Return on Capital Employed (ROCE) | 11.50% |
| Weighted Average Cost of Capital (WACC) | 5.84% |
| Revenue Per Employee | 5.21M |
| Profits Per Employee | 498,889 |
| Employee Count | 2,077 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 69.90 |
Taxes
In the past 12 months, NSE:ARTEMISMED has paid 354.63 million in taxes.
| Income Tax | 354.63M |
| Effective Tax Rate | 25.48% |
Stock Price Statistics
The stock price has increased by +10.00% in the last 52 weeks. The beta is 0.27, so NSE:ARTEMISMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +10.00% |
| 50-Day Moving Average | 266.68 |
| 200-Day Moving Average | 251.77 |
| Relative Strength Index (RSI) | 58.44 |
| Average Volume (20 Days) | 182,711 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ARTEMISMED had revenue of INR 10.81 billion and earned 1.04 billion in profits. Earnings per share was 6.56.
| Revenue | 10.81B |
| Gross Profit | 2.64B |
| Operating Income | 1.40B |
| Pretax Income | 1.39B |
| Net Income | 1.04B |
| EBITDA | 1.88B |
| EBIT | 1.40B |
| Earnings Per Share (EPS) | 6.56 |
Balance Sheet
The company has 2.06 billion in cash and 2.62 billion in debt, with a net cash position of -554.19 million or -3.50 per share.
| Cash & Cash Equivalents | 2.06B |
| Total Debt | 2.62B |
| Net Cash | -554.19M |
| Net Cash Per Share | -3.50 |
| Equity (Book Value) | 9.41B |
| Book Value Per Share | 59.16 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -1.05 billion, giving a free cash flow of 270.01 million.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -1.05B |
| Depreciation & Amortization | 480.66M |
| Net Borrowing | -166.08M |
| Free Cash Flow | 270.01M |
| FCF Per Share | 1.71 |
Margins
Gross margin is 24.38%, with operating and profit margins of 12.96% and 9.58%.
| Gross Margin | 24.38% |
| Operating Margin | 12.96% |
| Pretax Margin | 12.87% |
| Profit Margin | 9.58% |
| EBITDA Margin | 17.40% |
| EBIT Margin | 12.96% |
| FCF Margin | 2.50% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.16%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 0.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.92% |
| Buyback Yield | -1.45% |
| Shareholder Yield | -1.29% |
| Earnings Yield | 2.36% |
| FCF Yield | 0.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ARTEMISMED is 330.25, which is 22.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 330.25 |
| Price Target Difference | 22.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Sep 23, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |